AIMS: Young injection drug users (IDU) are at high risk for hepatitis C virus (HCV). We sought to determine whether perceiving one's injecting partner to be HCV positive was associated with decreased odds of engaging in receptive needle/syringe sharing (RNS) or ancillary equipment sharing (AES) with that partner. DESIGN: Cross sectional study. SETTING: 2003 to 2007 in San Francisco. PARTICIPANTS: 212 young (under age 30) IDU who were HCV antibody negative reported on 492 injecting partnerships. MEASUREMENTS: Self-reported RNS and AES within injecting partnerships. FINDINGS: RNS and AES (in the absence of RNS) occurred in 23% and 64% of injecting partnerships in the prior month. The odds of engaging in RNS were significantly lower for relationships in which the participant reported that his/her partner was HCV positive (odds ratio [OR] 0.49; 95% confidence interval [CI] 0.25-0.95). This association was attenuated when adjusted for reusing one's own needle/syringe (adjusted OR 0.57; 95% CI 0.28-1.15). The odds of engaging in AES were lower for participants who did not know the HCV status of their partner, only among non-sexual partnerships (OR 0.47; 95% CI 0.29-0.76). CONCLUSIONS: Because perceiving one's partner to be HCV positive was associated with decreased RNS, increased HCV testing and partner disclosure may be warranted. AES was common and was decreased only among non-sexual partnerships in which the HCV status of the partner was not known. This suggests that interventions to reduce AES in young IDU must be widespread.
AIMS: Young injection drug users (IDU) are at high risk for hepatitis C virus (HCV). We sought to determine whether perceiving one's injecting partner to be HCV positive was associated with decreased odds of engaging in receptive needle/syringe sharing (RNS) or ancillary equipment sharing (AES) with that partner. DESIGN: Cross sectional study. SETTING: 2003 to 2007 in San Francisco. PARTICIPANTS: 212 young (under age 30) IDU who were HCV antibody negative reported on 492 injecting partnerships. MEASUREMENTS: Self-reported RNS and AES within injecting partnerships. FINDINGS:RNS and AES (in the absence of RNS) occurred in 23% and 64% of injecting partnerships in the prior month. The odds of engaging in RNS were significantly lower for relationships in which the participant reported that his/her partner was HCV positive (odds ratio [OR] 0.49; 95% confidence interval [CI] 0.25-0.95). This association was attenuated when adjusted for reusing one's own needle/syringe (adjusted OR 0.57; 95% CI 0.28-1.15). The odds of engaging in AES were lower for participants who did not know the HCV status of their partner, only among non-sexual partnerships (OR 0.47; 95% CI 0.29-0.76). CONCLUSIONS: Because perceiving one's partner to be HCV positive was associated with decreased RNS, increased HCV testing and partner disclosure may be warranted. AES was common and was decreased only among non-sexual partnerships in which the HCV status of the partner was not known. This suggests that interventions to reduce AES in young IDU must be widespread.
Authors: Susanne B Montgomery; Justeen Hyde; Christine Johnson De Rosa; Louise Ann Rohrbach; Susan Ennett; S Marie Harvey; Michael Clatts; Ellen Iverson; Michele D Kipke Journal: Am J Drug Alcohol Abuse Date: 2002 Impact factor: 3.829
Authors: Jennifer L Evans; Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Ellen S Stein; Peter J Davidson; Andrew R Moss Journal: J Urban Health Date: 2003-03 Impact factor: 3.671
Authors: Martha E Montgomery; Robin S Fatch; Jennifer L Evans; Michelle Yu; Peter J Davidson; Kimberly Page; Judith A Hahn Journal: J Urban Health Date: 2013-06 Impact factor: 3.671
Authors: Chloe Le Marchand; Jennifer Evans; Kimberly Page; Peter J Davidson; Judith A Hahn Journal: Drug Alcohol Depend Date: 2012-07-20 Impact factor: 4.492
Authors: Kimberly Page; William Osburn; Jennifer Evans; Judith A Hahn; Paula Lum; Alice Asher; Eric Delwart; Leslie Tobler; Andrea L Cox; Michael P Busch Journal: Clin Infect Dis Date: 2012-10-22 Impact factor: 9.079